Evidence map›Paper›PMID 31439558›Full record

ArticleBMJ case reports2019

Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab.

Julien Pierrard, Bénédicte Petit, Sarah Lejeune, Emmanuel Seront

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Polyradiculoneuropathies associated with immune checkpoint inhibitors: are we facing a new nosological entity?Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Julien PierrardMedical Oncology, Hopital de Jolimont, Haine-Saint-Paul, Belgium.
Bénédicte PetitMedical Oncology, Hopital de Jolimont, Haine-Saint-Paul, Belgium.
Sarah LejeuneMedical Oncology, Hopital de Jolimont, Haine-Saint-Paul, Belgium.
Emmanuel SerontMedical Oncology, Hopital de Jolimont, Haine-Saint-Paul, Belgium.ORCID http://orcid.org/0000-0003-4807-7472
Hôpital de Jolimont · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increased use of immune checkpoint inhibitors (ICIs) has led to the observation of a variety of immune-related adverse events (irAEs). These irAEs occur usually within the first months after ICIs onset and can involve theorically all organs. We describe two rare irAEs occurring in a 70-year-old caucasian man who was treated with nivolumab for an advanced urothelial cancer of the left kidney. He developed an isolated adrenocorticotropic hormone deficiency that was diagnosed at week 19 and a neurological complication that appeared at week 79 and initially confounded with a lumbar spinal stenosis. Diagnosis of Guillain-Barré syndrome was finally confirmed with the complete resolution of symptoms after 5 days of intravenous immunoglobulin and corticosteroids. We highlight the importance of quickly recognising these potential life-threatening irAEs such as cortisol insufficiency and neurologic adverse events whose initially presentation could be non-specific.

Indexed as

Adrenocorticotropic HormoneAgedAntineoplastic Agents, ImmunologicalDiagnosis, DifferentialEndocrine System DiseasesGenetic Diseases, InbornGuillain-Barre SyndromeHumansHypoglycemiaMaleNivolumabUrethral NeoplasmsAdrenocorticotropic HormoneAntineoplastic Agents, ImmunologicalNivolumabadrenal disordersimmunological products and vaccinesneuromuscular diseaseurinary and genital tract disorders

Identifiers

PMID31439558
PMCPMC6720815
OpenAlexW2969578142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.